We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$6.58B
AUM Growth
-$16.9M
Cap. Flow
-$345M
Cap. Flow %
-5.24%
Top 10 Hldgs %
19.23%
Holding
670
New
207
Increased
92
Reduced
126
Closed
222

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$119M
2
ADI icon
Analog Devices
ADI
+$91.5M
3
PAYC icon
Paycom
PAYC
+$76.8M
4
PANW icon
Palo Alto Networks
PANW
+$71M
5
AZEK
The AZEK Co
AZEK
+$59.1M

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 14.97%
3 Industrials 11.6%
4 Consumer Discretionary 11.16%
5 Financials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
401
Procter & Gamble
PG
$338B
$820K 0.01%
+5,901
New +$783K
ARCE
402
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$800K 0.01%
+19,593
New +$862K
NCNO icon
403
nCino
NCNO
$2.11B
$797K 0.01%
+10,000
New +$798K
DNOW icon
404
DNOW Inc
DNOW
$3.03B
$785K 0.01%
+173,010
New +$1.31M
PRPB
405
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
$757K 0.01%
+75,300
New +$759K
QUIK icon
406
QuickLogic
QUIK
$250M
$730K 0.01%
234,674
FRLN
407
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$702K 0.01%
+3,000
New +$752K
IVA
408
Inventiva
IVA
$1.12B
$688K 0.01%
+58,200
New +$667K
BIOR
409
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$682K 0.01%
302
EHTH icon
410
eHealth
EHTH
$39.7M
$651K 0.01%
8,243
-25,157
-75% -$2.04M
DYN icon
411
Dyne Therapeutics
DYN
$4.92B
$589K 0.01%
+29,195
New +$641K
ADVM
412
DELISTED
Adverum Biotechnologies
ADVM
$572K 0.01%
+5,552
New +$831K
NARI
413
DELISTED
Inari Medical, Inc. Common Stock
NARI
$572K 0.01%
8,292
-23,229
-74% -$1.49M
JBHT icon
414
JB Hunt Transport Services
JBHT
$24.8B
$532K 0.01%
+4,206
New +$560K
CHPT icon
415
ChargePoint
CHPT
$160M
$528K 0.01%
+1,692
New +$368K
FND icon
416
Floor & Decor
FND
$6.41B
$518K 0.01%
+6,919
New +$475K
VC icon
417
Visteon
VC
$2.83B
$517K 0.01%
+7,474
New +$552K
ZSAN
418
DELISTED
Zosano Pharma Corporation
ZSAN
$479K 0.01%
8,456
TFII icon
419
TFI International
TFII
$11.5B
$478K 0.01%
11,434
-425,025
-97% -$17.9M
NET icon
420
Cloudflare
NET
$111B
$469K 0.01%
11,425
-303,168
-96% -$11.6M
VICI icon
421
VICI Properties
VICI
$28.7B
$467K 0.01%
19,974
-254,679
-93% -$5.72M
PLRX icon
422
Pliant Therapeutics
PLRX
$65M
$466K 0.01%
20,560
-50,000
-71% -$1.25M
PHR icon
423
Phreesia
PHR
$772M
$459K 0.01%
14,299
-8,848
-38% -$263K
XFOR icon
424
X4 Pharmaceuticals
XFOR
$432M
$456K 0.01%
2,247
PCG icon
425
PG&E
PCG
$37.7B
$452K 0.01%
48,100
-2,961,900
-98% -$27.4M

Similar funds

Alyeska Investment Group's Q3 2020 Portfolio in Review

As of Q3 2020, Alyeska Investment Group held 670 positions worth $6.58B, down 0.26% from $6.59B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Alyeska Investment Group withdrew a net $345M in Q3 2020, closing 222 positions and reducing 126 holdings. Its most notable exit was Texas Instruments, an estimated $142M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Microsoft worth $119M.

  • Alyeska Investment Group's largest Q3 2020 buy was Microsoft: 568,147 shares worth $119M.
  • Alyeska Investment Group added most to Paycom in Q3 2020, an estimated $76.8M increase.
  • Alyeska Investment Group's biggest Q3 2020 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Alyeska Investment Group fully exited Texas Instruments in Q3 2020, selling an estimated $142M.
  • Alyeska Investment Group's ten largest holdings make up 19% of its $6.58B portfolio in Q3 2020.
  • Alyeska Investment Group opened 207 new positions and closed 222 in Q3 2020.
  • Alyeska Investment Group's portfolio value fell 0.26% quarter-over-quarter to $6.58B.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.